Skip to main content
SpringerLink
Log in

Role of Cytokines

  • Chapter
  • First Online:
Immunopharmacology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  • Arend WP, Dayer JM. 1990. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheumat. 33:305–315.

    Article  PubMed  CAS  Google Scholar 

  • Asadullah K, Sterry W, Volk HD. 2003. Interleukin-10 therapy – Review of a new approach. Pharmacol Rev. 55:241–269.

    Article  PubMed  CAS  Google Scholar 

  • Atkins MB. 2002. Interleukin-2: Clinical applications. Semin Oncol. 29:12–17.

    Article  PubMed  CAS  Google Scholar 

  • Auron PE, Webb AC, Rosenwassser LJ, Mucci SF, et al. 1984. Nucleotide sequence of human monocyte interleukin 1 precursor CDA. Proc Nat Acad Sci USA. 81:7907–7911.

    Google Scholar 

  • Becknell B, Caligiuri MA. 2005. Interleukin 2 and interleukin 15, and their roles in human natural killer cells. Adv Immunol. 86:209–239.

    Article  PubMed  CAS  Google Scholar 

  • Bhatia M, Davenport V, Cairo MS. 2007. The role of interleukin-11 to prevent chemotherapy-induced cytopenia in patients with solid tumors, lymphomas, acute myeloid leukemia and bone marrow failure syndromes. Leuk Lymph. 48:9–15.

    Article  CAS  Google Scholar 

  • Bouchner BS, Klunk DA, Sterbinsky SA, Coffman RL, et al. 1995. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells.J Immuno. 154:799–803.

    Google Scholar 

  • Bradding P, Roberts JA, Britten KM, Montefort S, et al. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 10:471–480.

    PubMed  CAS  Google Scholar 

  • Buetler B, Greenwald D, Hulmes JD, Chang M, et al. 1985. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature. 316:552–554.

    Article  Google Scholar 

  • Charo IF, Romsohoff RM. 2006. The many roles of chemokines and chemokines receptors in inflammation. NEJM. 354:610–621.

    Article  PubMed  CAS  Google Scholar 

  • Colotta F, Dower SK, Sims JE, Mantovani A. 1994. The type II “decoy” receptor: A novel regulatory pathway for interleukin-1. Immunol Today. 15:562–566.

    Article  PubMed  CAS  Google Scholar 

  • Dinarello CA. 1984. Interleukin-1 and the pathogenesis of acute phase response. NEJM. 311:1413–1418.

    Article  PubMed  CAS  Google Scholar 

  • Dinarello CA. 1998. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314–25.

    Google Scholar 

  • Dinarello CA. 2000. The role of interleukin-1 receptor antagonist in blocking inflammation mediated by IL-1. NEJM. 343:732–734.

    Article  PubMed  CAS  Google Scholar 

  • Dinarello CA. 2002. The IL-1 family and inflammatory disease. Clin Exp Rheumatol. 20:S1–S13..

    PubMed  CAS  Google Scholar 

  • Dinarello CA. 2005. Blocking IL-1 in systemic inflammation. J Exp Med. 201:1355–1359.

    Article  PubMed  CAS  Google Scholar 

  • Du XX, Williams DA. 1994. Interleukin 11: A multifunctional growth factor derived from the hematopoietic microenvironment. Blood. 83:2023–2030.

    PubMed  CAS  Google Scholar 

  • Dubucquoi S, Desreumaux P, Janin A, Klein O, et al. 1994. Interleukin 5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion. J Exp Med. 179:703–708.

    Article  PubMed  CAS  Google Scholar 

  • Fernandez E, Lolis E. 2002. Structure, function and inhibition of chemokines. Ann Rev Pharmacol Toxicol. 42:469–499.

    Article  CAS  Google Scholar 

  • Flier J, Boorsma DM, Van Beek PJ, Niboer C, et al. 2001. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol. 194:398–405.

    Article  PubMed  CAS  Google Scholar 

  • Gaffen SL, Liu KD. 2004. Overview of interleukin-2 function, production and clinical applications. Cytokine. 28:109–123.

    Article  PubMed  CAS  Google Scholar 

  • Gerard C, Rollins BJ. 2001. Chemokines and disease. Nat Immunol. 2:108–115.

    Article  PubMed  CAS  Google Scholar 

  • Gracie JA, Robertson SE, McInnes IB. 2003. Interleukin-18. J Leukocyte Biol. 73:213–224.

    Article  PubMed  CAS  Google Scholar 

  • Grande C, Firvida JL, Navas V, Casal J. 2006. Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma. Anticancer Drugs. 17:1–12.

    Article  PubMed  CAS  Google Scholar 

  • Gray PW, Goeddel DV. 1982. Structure of the human interferon gene. Nature. 298:859–863.

    Article  PubMed  CAS  Google Scholar 

  • Horuk R. 1999. chemokine receptors and HIV-1. Immunol Today. 20:89–94.

    Article  PubMed  CAS  Google Scholar 

  • Howard M, Paul WE. 1982. Interleukins for B lymphocytes. Lymphokine Res. 1:1–4.

    PubMed  CAS  Google Scholar 

  • Ihle JN. 1995. Cytokine receptor signaling. Nature. 377:591–594.

    Article  PubMed  CAS  Google Scholar 

  • Ihle JN, Witthun BA, Quelle FW, Yamamoto K, et al. 1995. Signaling through the hematopoietic cytokine receptors. Ann Rev Immunol. 13:369–398.

    Article  CAS  Google Scholar 

  • Isaacs A, Lindermann J. 1957. Virus interference. I. The interferon. Proc Roy Soc Lond Biol Sci. 147:258–267.

    Google Scholar 

  • Issac C, Robert NJ, Bailey FA, Schuster MW, et al. 1997. Randomized placebo-controlled study of recombinant human interleukin 11 to prevent chemotherapy induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin. J Clin Oncol. 15:3368–3377.

    Google Scholar 

  • Kaczmarski RS, Mufti GJ. 1993. Low-dose filgrastim therapy for chronic neutropenia. NEJM. 329:1280–1281.

    Article  PubMed  CAS  Google Scholar 

  • Kaczmarski RS, Pazniak A, Lakhani A, Harvey E, Mufti GJ. 1993. A pilot study of low-dose recombinant human granulocyte-macrophage colony-stimulating factor in chronic neutropenia. Br J Hematol. 84:338–340.

    Article  CAS  Google Scholar 

  • Kaminuma O, Mori A, Kitamura N, Hashimoto T, et al. 2005. Role of GAGA-3 in IL-5 gene transcription by CD4+ T cells of asthmatic patients. Int Arch All Immunol. 137:55–59.

    Article  CAS  Google Scholar 

  • Kishimoto T, Akira S, Narazaki M, Taga T. 1995. Interleukin-6 family of cytokines. Blood. 86:1243–1254.

    PubMed  CAS  Google Scholar 

  • Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, et al. 2005. Sargramostim for active Crohn’s disease. NEJM. 352:2193–2201.

    Article  PubMed  CAS  Google Scholar 

  • Laing K, Secombes C. 2004. Chemokines. Dev Comp Immunol. 28:443–460.

    Article  PubMed  CAS  Google Scholar 

  • Larsen CM, Faulenbach M, Vaag A, Velund A, et al. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. NEJM. 356:1517–1526.

    Article  PubMed  CAS  Google Scholar 

  • Lee JS, Campbell HD, Kozak CA, Young IG. 1989. The IL-4 and IL-5 genes are closely linked and are part of a cytokine gene cluster on mouse chromosome 11. Somat Cell Mol Genet. 15:143–152.

    Article  PubMed  CAS  Google Scholar 

  • Leischke GJ, Burgess AW. 1992. Granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor. NEJM. 327:28–35.

    Article  Google Scholar 

  • Locksley RM, Killeen N, Lenardo MJ. 2001. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell. 104:487–501.

    Article  PubMed  CAS  Google Scholar 

  • Lotz MT, Matory YL, Rayner AA. 1986. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer. 58:2764–2772.

    Article  Google Scholar 

  • Louahed J, Kermouni A, Van Snick J, Renauld JC. 1995. IL-9 induces expression of granzymes and high affinity IgE receptor in murine T helper clones. J Immunol. 154:5061–5070.

    PubMed  CAS  Google Scholar 

  • Louahed J, Toda M, Jen J, Hamid Q, et al. 2000. Interleukin-9 upregulates mucus expression in the airways. Am J Resp Cell Mol Biol. 22:649–656.

    CAS  Google Scholar 

  • Louahed J, Zhou Y, Maloy WL, Rani PU, et al. 2001. Interleukin 9 promotes influx and local maturation of eosinophils. Blood. 97:1035–1042.

    Article  PubMed  CAS  Google Scholar 

  • Ma A, Koka R, Burkett P. 2006. Diverse functions of IL-2, IL-15 and IL-7 in lymphoid homeostasis. Ann Rev Immunol. 24:657–679.

    Article  CAS  Google Scholar 

  • Malozowski S, Sahlroot JT, Mandruup-Poulsen T, Seifert B, et al. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. NEJM. 357:302–303.

    Article  PubMed  CAS  Google Scholar 

  • Massa M, Rosti V, Ferrario M, Campanelli R, et al. 2005. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 105:199–206.

    Article  PubMed  CAS  Google Scholar 

  • McDermott DF. 1007. Update on the application of interleukin 2 in the treatment of renal cell carcinoma. Clin Can Res. 13:716S–720S..

    Google Scholar 

  • Mentink MM, Wynn TA. 2004. Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease. Immunol Rev. 202:191–202.

    Article  Google Scholar 

  • Milburn MV, Hassell AM, Lambert MH, Jordan SR, et al. 1993. A novel dimer configuration revealed by the crystal structure at 2.4A resolution of human initerleukin-5. Nature. 363:172–176.

    Article  PubMed  CAS  Google Scholar 

  • Mocellin S, Panelli MC, Wang E, Nagorsen D, et al. 2003. The dual role of IL-10. Trends Immunol. 4:36–43.

    Article  Google Scholar 

  • Moore KW, de-Waal R, Coffman RL, O’Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol. 19:683–765.

    Article  CAS  Google Scholar 

  • Morstyn G, Campbell L, Souza LM, Alton NK, et al. 1988. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1:667–672.

    Article  PubMed  CAS  Google Scholar 

  • Murdoch C, Finn A. 2001. Chemokine receptors and the role in inflammation and infectious disease. J Am Soc Hematol. 95:3032–3043.

    Google Scholar 

  • Murphy PM, International Union of Pharmacology. 2002. Update on chemokine receptor nomenclature. Pharmacol Rev. 54:227–229.

    Google Scholar 

  • Murray PJ. 2006. Understanding and exploiting the endogenous interleukin 10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol. 6:379–386.

    Article  PubMed  CAS  Google Scholar 

  • Nagata S, Tsuchiya M, Asano S, Kaziro Y, et al. 1986. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature. 319:415–418.

    Article  PubMed  CAS  Google Scholar 

  • Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, et al. 1990. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte-colony stimulating factor. Blood. 76:36–43.

    PubMed  CAS  Google Scholar 

  • Nelson, BH. 2002. Interleukin-2 signaling and the maintenance of self tolerance. Curr Dire Autoimm. 5:92–112.

    Article  CAS  Google Scholar 

  • Nicolaides NC, Holroyd KJ, Ewart SL, Eleff SM, et al. 1997. Interleukin-9: A Candidate gene for asthma. Proc Nat Acad Sci USA. 94:13175–13180.

    Google Scholar 

  • Novick D, Kim SH, Fantuzzi G, Rezinkov L, et al. 1999. Interleukin-18 binding protein: A novel modulator of TH1 cytokine response. Immunity. 10:127–136.

    Article  PubMed  CAS  Google Scholar 

  • Ohki Y, Heissig B, Sato Y, Akiyama H, et al. 2005. Granulocyte colony stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 19:2005–2007.

    PubMed  CAS  Google Scholar 

  • Old LJ. 1985. Tumor necrosis factor. Science. 230:630–632.

    Article  PubMed  CAS  Google Scholar 

  • Pau AK, Tavel JA. 2002. Therapeutic use of interleukin-2 in HIV-infected patients. Curr Opin Pharmacol. 2:433–439.

    Article  PubMed  CAS  Google Scholar 

  • Pestkoi S, Krause CD, Sarkar D, Walter MR. 2004. Interleukin-10 and related cytokines and receptors. Ann Rev Immunol. 22:929–979.

    Article  Google Scholar 

  • Pilette C, Ouadrhiri Y, Van Snick J, Renauld JC, et al. 2002. Interleukin-9 inhibits oxidative burst in LPS-stimulated human blood monocytes through TGF-β. J Immunol. 168:4103–4111.

    PubMed  CAS  Google Scholar 

  • Pizarro TT, Cominelli F. 2007. Cloning of IL-1 and the birth of a new era in cytokine biology. J Immunol. 178:5411–5412.

    PubMed  CAS  Google Scholar 

  • Renauld JC, Houssiau F, Druez C, Uyttenhove C, et al. 1993. Interleukin-9. Int Rev Exp Path. 34:99–109.

    PubMed  Google Scholar 

  • Renauld JC, Vink A, Louahed J, VanSnick J. 1995. Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood. 85:1300–1305.

    PubMed  CAS  Google Scholar 

  • Sanderson CJ. 1992. Interleukin-5, eosinophils and disease. Blood. 79:3101–3109.

    PubMed  CAS  Google Scholar 

  • Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2003. Interferon-γ, an overview of signals, mechanisms and functions. J Leukocyte Biol. 75:163–189.

    Article  PubMed  Google Scholar 

  • Scott DL, Kingsley GH. 2006. Tumor necrosis factor inhibitors for rheumatoid arthritis. NEJM. 355:704–712.

    Article  PubMed  CAS  Google Scholar 

  • Sen GC. 2003. Viruses and interferons. Ann Rev Microbiol. 55:255–281.

    Article  Google Scholar 

  • Shen HH, Ochkur SI, McGarry MP, Crosby JR, et al. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol. 170:3296–3305.

    PubMed  CAS  Google Scholar 

  • Smith, KA, Gilbride KJ, Favata MF. 1980. Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. Nature. 287:853–855.

    Article  PubMed  CAS  Google Scholar 

  • Taniguchi T, Matsui H, Fujita T, Kakaoka C. 1983. Structure and expression of a cloned cDNA for human interleukin-2. Nature. 302:205–310.

    Article  Google Scholar 

  • Taniguchi T, Takaoka A. 2002. The interferon-alpha/beta system in antiviral responses: A multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol. 14:111–116.

    Article  PubMed  CAS  Google Scholar 

  • Temesgen Z. 2006. Interleukin-2 for the treatment of human immunodeficiency virus. Drugs Today. 42:791–801.

    Article  PubMed  CAS  Google Scholar 

  • Tepler I, Elias L, Smith JW, Hussein M, et al. 1996. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood. 87:3607–3614.

    PubMed  CAS  Google Scholar 

  • Trebst C, Sorensen TL, Kivisakk P, Cathcart MK, et al. 2001. CCR1+/CCR5+ mononuclear phagocyte accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol. 159:1701–1710.

    Article  PubMed  CAS  Google Scholar 

  • Valgimigli M, Rigolin GM, Cittani C, Malagutti P, et al. 2005. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans. Eur Heart J. 26:1838–1845.

    Article  PubMed  CAS  Google Scholar 

  • Van Damme J, De Ley M, Opdenakker G, Billiau A, et al. 1985. Homogenous interferon-inducing 22 K factor is related to endogenous pyrogen and interleukin-1. Nature. 314:266–268.

    Article  PubMed  Google Scholar 

  • Van Leeuwen BH, Martinson ME, Webb GC, Young IG. 1989. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5 and GM-CSF genes, on human chromosome 5. Blood. 73:1142–1148.

    PubMed  Google Scholar 

  • Waldmann TA. 2006. The biology of interleukin-2 and interleukin-15: Implications for cancer therapy and vaccine design. Nat Rev Immunol. 6:595–601.

    Article  PubMed  CAS  Google Scholar 

  • Walter MR, Cook, WJ, Zhao BG, Cameron RP, et al. 1992. Crystal structure of recombinant human interleukin-4. J Biol Chem. 267:20371–20376.

    PubMed  CAS  Google Scholar 

  • Weaver CH, Schulman KA, Wilson-Relyea B, Birch R, et al. 2000. Randomized trial of Filgrastim, Sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral blood stem cells. J Clin Oncol. 18:43–53.

    PubMed  CAS  Google Scholar 

  • Wills-Karp M, Luyiambazi J, Xu X, Schofield B, et al. 1998. Interleukin-13: Central mediator of allergic asthma. Science. 282:2258–2261.

    Article  PubMed  CAS  Google Scholar 

  • Wynn TA. 2003. IL-13 effector functions. Ann Rev Immunol. 21:425–456.

    Article  CAS  Google Scholar 

  • Yokota T, Otsuka K, Mosmann T, Banchereau J, et al. 1986. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell and T-cell stimulating activities. Proc Nat Acad Sci USA. 83:5894–5898.

    Google Scholar 

  • Zdanov A. 2004. Structural features of the interleukin-10 family of cytokines. Curr Pharm Design. 10-:3873–3884..

    Article  Google Scholar 

  • Zheng LM, Ojcius DM, Garaud F, Roth C, et al. 1996. Interleukin-10 inhibits tumor metastasis through an NK cell dependent mechanism. J Exp Med. 184:579–584.

    Article  PubMed  CAS  Google Scholar 

  • Zhou Y, McLane M, Levitt RC. 2001. TH2 cytokines and asthma: Interleukin 9 as therapeutic target for asthma. Resp Res. 2:80–84.

    Article  CAS  Google Scholar 

  • Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. 2003. Chemokines in asthma: Cooperative interaction between chemokine and IL-13. J All Clin Immunol. 111:227–242.

    Article  CAS  Google Scholar 

  • Zohlnhofer D, Ott I, Mehilli J, Schoming K, et al. 2006. Stem cell mobilization by granulocyte-colony-stimulating factor in patients with acute myocardial infarction. JAMA. 295: 1003–1010.

    Article  PubMed  Google Scholar 

  • Zurawski G, de Vries JE. 1994. Interleukin 13, an interleukin-4 like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today. 15:19–26.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Creighton University Medical Center, Omaha, NE, USA

    Manzoor M. Khan Ph.D.

Authors
  1. Manzoor M. Khan Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manzoor M. Khan Ph.D. .

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Khan, M.M. (2008). Role of Cytokines. In: Immunopharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-77976-8_2

Download citation

Publish with us

Policies and ethics

Search

Navigation